rs116711766

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 1P and 13B. PP2BP4_StrongBP6BS1BS2

The NM_000702.4(ATP1A2):​c.340G>A​(p.Gly114Ser) variant causes a missense change. The variant allele was found at a frequency of 0.000804 in 1,614,102 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00075 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00081 ( 3 hom. )

Consequence

ATP1A2
NM_000702.4 missense

Scores

4
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:15

Conservation

PhyloP100: 4.14

Publications

5 publications found
Variant links:
Genes affected
ATP1A2 (HGNC:800): (ATPase Na+/K+ transporting subunit alpha 2) The protein encoded by this gene belongs to the family of P-type cation transport ATPases, and to the subfamily of Na+/K+ -ATPases. Na+/K+ -ATPase is an integral membrane protein responsible for establishing and maintaining the electrochemical gradients of Na and K ions across the plasma membrane. These gradients are essential for osmoregulation, for sodium-coupled transport of a variety of organic and inorganic molecules, and for electrical excitability of nerve and muscle. This enzyme is composed of two subunits, a large catalytic subunit (alpha) and a smaller glycoprotein subunit (beta). The catalytic subunit of Na+/K+ -ATPase is encoded by multiple genes. This gene encodes an alpha 2 subunit. Mutations in this gene result in familial basilar or hemiplegic migraines, and in a rare syndrome known as alternating hemiplegia of childhood. [provided by RefSeq, Oct 2008]
ATP1A2 Gene-Disease associations (from GenCC):
  • hemiplegic migraine-developmental and epileptic encephalopathy spectrum
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • migraine, familial hemiplegic, 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
  • fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, and dysmorphic facies
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, ClinGen
  • alternating hemiplegia of childhood 1
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • developmental and epileptic encephalopathy 98
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • alternating hemiplegia of childhood
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial or sporadic hemiplegic migraine
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

PP2
Missense variant in the ATP1A2 gene, where missense mutations are typically associated with disease (based on misZ statistic). The gene has 63 curated pathogenic missense variants (we use a threshold of 10). The gene has 10 curated benign missense variants. Gene score misZ: 4.7713 (above the threshold of 3.09). Trascript score misZ: 6.824 (above the threshold of 3.09). GenCC associations: The gene is linked to developmental and epileptic encephalopathy 98, fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, and dysmorphic facies, migraine, familial hemiplegic, 2, alternating hemiplegia of childhood, alternating hemiplegia of childhood 1, familial or sporadic hemiplegic migraine, hemiplegic migraine-developmental and epileptic encephalopathy spectrum.
BP4
Computational evidence support a benign effect (MetaRNN=0.011987209).
BP6
Variant 1-160123375-G-A is Benign according to our data. Variant chr1-160123375-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 128485.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000749 (114/152210) while in subpopulation NFE AF = 0.000926 (63/68018). AF 95% confidence interval is 0.000742. There are 0 homozygotes in GnomAd4. There are 53 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 3 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000702.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP1A2
NM_000702.4
MANE Select
c.340G>Ap.Gly114Ser
missense
Exon 4 of 23NP_000693.1P50993

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP1A2
ENST00000361216.8
TSL:1 MANE Select
c.340G>Ap.Gly114Ser
missense
Exon 4 of 23ENSP00000354490.3P50993
ATP1A2
ENST00000857225.1
c.340G>Ap.Gly114Ser
missense
Exon 4 of 23ENSP00000527284.1
ATP1A2
ENST00000969831.1
c.340G>Ap.Gly114Ser
missense
Exon 4 of 23ENSP00000639890.1

Frequencies

GnomAD3 genomes
AF:
0.000756
AC:
115
AN:
152092
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000145
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000721
Gnomad ASJ
AF:
0.00663
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000849
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000941
Gnomad OTH
AF:
0.000955
GnomAD2 exomes
AF:
0.000815
AC:
205
AN:
251448
AF XY:
0.000787
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.000781
Gnomad ASJ exome
AF:
0.00546
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000693
Gnomad NFE exome
AF:
0.000844
Gnomad OTH exome
AF:
0.00147
GnomAD4 exome
AF:
0.000810
AC:
1184
AN:
1461892
Hom.:
3
Cov.:
31
AF XY:
0.000788
AC XY:
573
AN XY:
727246
show subpopulations
African (AFR)
AF:
0.000149
AC:
5
AN:
33480
American (AMR)
AF:
0.000984
AC:
44
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00582
AC:
152
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000464
AC:
4
AN:
86258
European-Finnish (FIN)
AF:
0.000824
AC:
44
AN:
53418
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.000796
AC:
885
AN:
1112012
Other (OTH)
AF:
0.000811
AC:
49
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
77
154
232
309
386
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000749
AC:
114
AN:
152210
Hom.:
0
Cov.:
32
AF XY:
0.000712
AC XY:
53
AN XY:
74422
show subpopulations
African (AFR)
AF:
0.000144
AC:
6
AN:
41526
American (AMR)
AF:
0.000720
AC:
11
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00663
AC:
23
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4816
European-Finnish (FIN)
AF:
0.000849
AC:
9
AN:
10600
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000926
AC:
63
AN:
68018
Other (OTH)
AF:
0.000945
AC:
2
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
5
10
16
21
26
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0257
Hom.:
38
Bravo
AF:
0.000910
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000814
AC:
7
ExAC
AF:
0.000700
AC:
85
EpiCase
AF:
0.000654
EpiControl
AF:
0.000771

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
3
not provided (4)
-
-
3
not specified (3)
-
-
2
Alternating hemiplegia of childhood 1 (2)
-
-
2
Migraine, familial hemiplegic, 2 (2)
-
-
1
Developmental and epileptic encephalopathy 98 (1)
-
-
1
Familial hemiplegic migraine (1)
-
-
1
Fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, and dysmorphic facies (1)
-
-
1
Inborn genetic diseases (1)
-
-
1
Migraine, familial hemiplegic, 2;C3549447:Alternating hemiplegia of childhood 1;C5562015:Fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, and dysmorphic facies;C5562017:Developmental and epileptic encephalopathy 98 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.087
BayesDel_addAF
Benign
-0.17
T
BayesDel_noAF
Benign
-0.090
CADD
Uncertain
25
DANN
Uncertain
0.99
DEOGEN2
Benign
0.37
T
Eigen
Benign
-0.14
Eigen_PC
Benign
0.071
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.89
D
M_CAP
Benign
0.019
T
MetaRNN
Benign
0.012
T
MetaSVM
Benign
-0.61
T
MutationAssessor
Benign
1.1
L
PhyloP100
4.1
PrimateAI
Uncertain
0.76
T
PROVEAN
Benign
-1.3
N
REVEL
Benign
0.29
Sift
Benign
0.44
T
Sift4G
Benign
0.39
T
Polyphen
0.0040
B
Vest4
0.30
MVP
0.89
MPC
0.75
ClinPred
0.028
T
GERP RS
5.1
Varity_R
0.19
gMVP
0.69
Mutation Taster
=83/17
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs116711766; hg19: chr1-160093165; API